The Chemours Company $CC Shares Sold by RFG Advisory LLC

RFG Advisory LLC decreased its holdings in shares of The Chemours Company (NYSE:CC) by 47.7% during the 4th quarter, Holdings Channel.com reports. The firm owned 56,320 shares of the specialty chemicals company’s stock after selling 51,435 shares during the period. RFG Advisory LLC’s holdings in Chemours were worth $664,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in CC. Baird Financial Group Inc. purchased a new stake in shares of Chemours during the 1st quarter valued at $148,000. Royal Bank of Canada raised its position in shares of Chemours by 6.8% in the 1st quarter. Royal Bank of Canada now owns 585,702 shares of the specialty chemicals company’s stock worth $7,926,000 after buying an additional 37,382 shares during the period. AQR Capital Management LLC acquired a new position in Chemours in the first quarter valued at $161,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Chemours by 149.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 43,243 shares of the specialty chemicals company’s stock valued at $593,000 after acquiring an additional 25,899 shares during the last quarter. Finally, Empowered Funds LLC purchased a new stake in Chemours during the first quarter valued at about $403,000. Hedge funds and other institutional investors own 76.26% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on CC shares. Truist Financial increased their target price on shares of Chemours from $27.00 to $30.00 and gave the stock a “buy” rating in a research report on Tuesday, April 28th. Zacks Research upgraded shares of Chemours from a “strong sell” rating to a “hold” rating in a research note on Friday, April 24th. UBS Group increased their price objective on shares of Chemours from $29.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday. Mizuho set a $30.00 target price on shares of Chemours in a research note on Wednesday. Finally, Morgan Stanley lifted their target price on shares of Chemours from $15.00 to $17.00 and gave the company an “equal weight” rating in a report on Monday, February 23rd. Five research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Chemours has a consensus rating of “Hold” and an average price target of $21.70.

Chemours Price Performance

CC stock opened at $23.06 on Monday. The stock’s 50 day moving average is $21.15 and its two-hundred day moving average is $16.61. The Chemours Company has a 52-week low of $9.13 and a 52-week high of $28.67. The company has a market capitalization of $3.47 billion, a PE ratio of -8.73 and a beta of 1.47. The company has a quick ratio of 0.87, a current ratio of 1.82 and a debt-to-equity ratio of 18.98.

Chemours (NYSE:CC) last issued its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $0.05 EPS for the quarter, topping the consensus estimate of ($0.05) by $0.10. Chemours had a negative net margin of 6.82% and a positive return on equity of 52.49%. The business had revenue of $1.38 billion for the quarter, compared to analysts’ expectations of $1.40 billion. During the same quarter last year, the company posted $0.13 earnings per share. The company’s quarterly revenue was up 1.0% compared to the same quarter last year. Analysts predict that The Chemours Company will post 1.32 earnings per share for the current fiscal year.

Chemours Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 16th. Investors of record on Sunday, May 17th will be paid a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a yield of 1.5%. The ex-dividend date is Friday, May 15th. Chemours’s dividend payout ratio is presently -13.26%.

About Chemours

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.